Anti-Inflammatory Agents, Non-SteroidalCyclooxygenase 2 InhibitorsIbuprofenCyclooxygenase InhibitorsDiclofenacNaproxenGastrointestinal DiseasesAspirinKetoprofenCyclooxygenase 2Prostaglandin-Endoperoxide SynthasesAcetaminophenSulfonamidesSulindacPiroxicamPyrazolesSulfonesThiazinesAnalgesics, Non-NarcoticCyclooxygenase 1IndomethacinLactonesEtodolacNitrobenzenesTreatment OutcomeStomach UlcerGastrointestinal HemorrhageDose-Response Relationship, DrugOsteoarthritisPainPeptic UlcerDrug Therapy, CombinationDrug-Related Side Effects and Adverse ReactionsSafety-Based Drug WithdrawalsDouble-Blind MethodAnalgesicsKetorolacMisoprostolDrug InteractionsIsoenzymesAnalgesics, OpioidAdministration, TopicalRisk FactorsAdministration, OralPeptic Ulcer HemorrhageGastric MucosaArthritisPain MeasurementTime FactorsPain, PostoperativeDinoprostoneProspective StudiesDrug Administration ScheduleClinical Trials as TopicAnti-Ulcer AgentsAnti-Inflammatory AgentsMembrane ProteinsRandomized Controlled Trials as TopicDrug EruptionsDrug HypersensitivityDrug PrescriptionsAntipsychotic AgentsAntineoplastic AgentsDuodenal UlcerProton Pump InhibitorsChemopreventionArthritis, RheumatoidProstaglandinsCase-Control StudiesRetrospective StudiesAnticarcinogenic AgentsThiazolesStomach DiseasesIntestinal DiseasesTolmetinFollow-Up StudiesMorphineDrug UtilizationUlcerGlucocorticoidsSalicylatesNeoplasmsNauseaPlacebosProstaglandin AntagonistsColorectal NeoplasmsDrug CombinationsDelayed-Action PreparationsAnalgesiaEdemaRisk AssessmentUpper Gastrointestinal TractCohort StudiesCross-Over StudiesDrug CostsAdverse Drug Reaction Reporting SystemsRats, Sprague-DawleyVomitingApoptosisGrowth Differentiation Factor 15